a comparison of product dependence among cigarette only, ENDS only, and dual users: Findings from Wave 3 (2015-2016) of the PaTh study.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
Kaplan (2020)
Blood Nicotine Predicts the Behavioral Economic abuse Liability of Reduced-Nicotine Cigarettes.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
Kaplan (2022)
Electronic Cigarette Use, Misuse, and harm.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
Kathuria (2022)
Electronic cigarette use and risk of cigarette and smokeless tobacco initiation among adolescent boys: a propensity score matched analysis.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
Keller-hamilton (2021)
Reinforcement enhancement by nicotine: a novel abuse-liability assessment of e-cigarettes in young adults.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
Kirshenbaum (2022)
E-cigarette device type and combustible tobacco use: Results from a pooled analysis of 10,482 youth.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
Kong (2022)
Nicotine Dependence of Electronic Cigarette, Dual Combustible and Electronic Cigarette Users.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
Lee (2021)
Further investigation of gateway effects using the PaTh study.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
Lee (2020)
Examining the relationship of vaping to smoking initiation among US youth and young adults: a reality check.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
Levy (2019)
Understanding perceived addiction to and addictiveness of electronic cigarettes among electronic cigarette users: a cross-sectional analysis of the International Tobacco Control Smoking and Vaping (ITC 4CV) England Survey.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
Lohner (2023)